Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Nov 2, 2015 yancopoulos george Officer Automatic Sell 43,348 561.75 - 580.29
Nov 6, 2015 van plew daniel p Officer Disposition (Non Open Market) 6,063 559.49
Oct 30, 2015 yancopoulos george Officer Automatic Sell 96,122 559.08
Nov 9, 2015 stahl neil Officer Sell 22,101 558.37 - 563.41
Dec 29, 2015 mccorkle douglas s Officer Automatic Sell 3,954 552.08
Sep 21, 2015 brown michael s Director Automatic Sell 3,000 551.55
Nov 10, 2015 van plew daniel p Officer Sell 5,123 551.45 - 557.14
Sep 17, 2015 baker charles a Director Automatic Sell 5,000 550.00
Jul 15, 2015 goldstein joseph l Director Automatic Sell 2,000 550.00
Dec 10, 2015 brown michael s Director Automatic Sell 3,000 543.55 - 547.50
Dec 2, 2015 yancopoulos george Officer Automatic Sell 43,348 542.72 - 555.26
Jul 27, 2015 sanofi Beneficial Owner (10% or more) Automatic Buy 10,639 530.71 - 542.28
Jun 22, 2015 goldstein joseph l Director Automatic Sell 2,000 526.85
Sep 23, 2015 sanofi Beneficial Owner (10% or more) Buy 147,209 523.43 - 539.98
May 22, 2015 ingram robert alexander Director Disposition (Non Open Market) 3,788 516.48
May 22, 2015 van plew daniel p Officer Disposition (Non Open Market) 21,680 516.48
May 22, 2015 mccorkle douglas s Officer Sell 13,000 515.60
May 27, 2015 sing george l Director Sell 5,000 515.00
May 22, 2015 goldstein joseph l Director Sell 4,000 513.74 - 514.81
May 27, 2015 ingram robert alexander Director Sell 1,379 513.39
Showing 21-40 of 1029 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)